Hyperinsulinism

8

Review clinical trials related to Hyperinsulinism. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

The primary objective of the study is to assess metabolic plasma markers of insulin resistance in patients with early-stage HER2-negative breast cancers receiving dapagliflozin concomitant with neoadjuvant therapy.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Yale UniversityUpdated: May 22, 2026Locations: 1
Eligibility criteria

Weekly or dose dense paclitaxel, followed by dose dense doxorubicin plus cycloph... [+18]

Participants who underwent partial excisional biopsy or lumpectomy, segmental ma... [+10]

Status: Recruiting

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ali ChappellUpdated: May 1, 2026Locations: 1Duration: 1 Year
Eligibility criteria

Fasting insulin [+3]

Status: Recruiting

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

The investigators are doing this study to learn more about how to prevent type 2 diabetes in teenage girls. The purpose of this study is to find out if taking part in a cognitive-behavioral therapy group, exercise training group, or a combination of cognitive-behavioral therapy and exercise training groups, decreases stress, improves mood, increases physical activity and physical fitness, and decreases insulin resistance among teenagers at risk for diabetes.

Participants needed: 300
Trial details
Age: 12-17Biological sex: FemaleType: InterventionalSponsor: Colorado State UniversityUpdated: Apr 22, 2026Locations: 2
Eligibility criteria

Female [+4]

T2D/ Type 1 Diabetes (T1D) or any major medical condition (e.g. cardiovascular,... [+4]

Status: Recruiting

Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)

This observational 'recruit by genotype' study aims to provide insights into the cellular and molecular pathways underlying beta cell disorders and their physiological consequences. Eligible individuals are those with and without a pathogenic genetic variant, acting as case and control, respectively. Using a "recruit by genotype" approach, the researchers will perform detailed and specific analysis according to the individual's genetic variant. The study's main aims are to : 1) identify and describe biomarkers and cellular features in blood samples that occur because of the rare causal genetic variant; 2) study the altered physiology or cellular function that are due to the rare causal genetic variant. Participants will attend a study visit that will entail: * Consent * Data collection * Height and weight measures * Blood samples * MRI (optional), dependent on genotype and sub-study objectives. There is no treatment and the participants' normal clinical care will be unaffected and will continue uninterrupted. A small subset of participants may be invited for further sub-studies in the future. Researchers may recruit sex-matched healthy controls (without the variant of interest) with similar age and BMI (age: +/-15%, BMI: +/- 3 kg/m2) for specified case-control studies.

Participants needed: 50
Trial details
Age: 6-99Biological sex: AllType: ObservationalSponsor: University of ExeterUpdated: Jan 16, 2026Locations: 1
Eligibility criteria

Mental capacity to give informed consent [+3]

Lack of mental capacity to give informed consent [+9]

Status: Recruiting

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.

Participants needed: 100
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Dec 19, 2025Locations: 1
Eligibility criteria

Patients with confirmed hyperinsulinemic hypoglycemia, diagnosed by elevated ins... [+3]

Any other major illness or condition that in the investigator's judgment will su... [+2]

Status: Recruiting

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

The aim of the present study is to investigate a) the presence of subclinical markers of vascular, myocardial and endothelial function in women with PCOS b) the acute alterations in these markers during the oral glucose tolerance test (OGTT) c) the impact of potential treatment interventions in these markers.

Participants needed: 120
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Attikon HospitalUpdated: Nov 19, 2025Locations: 1
Eligibility criteria

Age > 16 years old [+5]

Disorders with clinical presentation similar to PCOS: thyroid disease, hyperprol... [+6]

Status: Recruiting

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

The goals of this project are to build an experimental tool to dissect out in vivo pancreatic beta cell mass (BCM) and beta cell function (BCF) and to assess for the first time these two determinants of beta cell functional mass (BCFxM) in obesity and in various stages of type 1 and type 2 diabetes mellitus.

Participants needed: 70
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Azienda Ospedaliero-Universitaria di ParmaUpdated: Mar 18, 2025Locations: 1
Eligibility criteria

Age ≥18 years; ≤ 75 years [+3]

Able to understand methods, goals, and implications of the research and of deliv... [+18]

Status: Recruiting

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

The goal of this study is to test whether monitoring insulin levels and using pioglitazone to treat hyperglycemia and hyperinsulinemia in patients treated with Alpelisib for metastatic breast cancer is feasible and safe, and to assess the rates of glycemic control, dose reductions and treatment discontinuation and the progression free survival of patients treated with this regimen.

Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18-85Biological sex: FemaleType: InterventionalSponsor: Rambam Health Care CampusUpdated: Mar 3, 2023Locations: 1
Eligibility criteria

Patients with ER positive HER2 negative metastatic breast cancer, harboring an a... [+3]

Impairment of gastrointestinal (GI) function or GI disease that may significantl... [+5]